The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Uniflu Plus with Vitamin C Tablets

30 mg/10 mg/15 mg/500 mg/10 milligram(s) Tablet

Phoenix LabsPA1113/006/001

Main Information

Trade NameUniflu Plus with Vitamin C Tablets
Active SubstancesParacetamol
Codeine phosphate hemihydrate
Diphenhydramine hydrochloride
Phenylephrine hydrochloride
Caffeine
Ascorbic acid
Strength30 mg/10 mg/15 mg/500 mg/10 milligram(s)
Dosage FormTablet
Licence HolderPhoenix Labs
Licence NumberPA1113/006/001

Group Information

ATC CodeN02BE Anilides
N02BE51 paracetamol, combinations excl. psycholeptics

Status

Authorised/WithdrawnAuthorised
Licence Issued30/10/1998
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back